Clinical Trial: A Phase II Study of NB001 for Acute Migraine Treatment

U.S., May 12 -- ClinicalTrials.gov registry received information related to the study (NCT07577050) titled 'A Phase II Study of NB001 for Acute Migraine Treatment' on April 07.

Brief Summary: The goal of this observational study is to Evaluate the Efficacy and Safety of NB001 for the Acute Treatment of Migraine in Adult patients diagnosed with migraine.

Study Start Date: April 20

Study Type: INTERVENTIONAL

Condition: Migraine

Intervention: DRUG: One tablet of NB001 plus three tablets of placebo

Take 1 tablet of NB001 + 3 tablets of placebo at the onset of moderate-to-severe acute migraine.

DRUG: Two tablets of NB001 plus two tablets of placebo

Take 2 tablets of NB001 plus 2 tablets of placebo at the onset of moderate-to-severe acu...